PharmXchange, the digital sales and marketing platform launched in June, has announced that Arrotex Pharmaceuticals is the latest major supplier to join.
PharmXchange allows suppliers to offer a tailored range of feature-rich sales and marketing solutions, integrated with the PharmX EDI gateway, to the whole pharmacy market and is rapidly gaining momentum as it reaches the end of the controlled pilot phase.
This phase has involved over 200 pharmacies and 20 suppliers in validating the operation of the platform and preparation for rapid scaling.
“PharmXchange fits directly into our vision of making it easier for Community Pharmacies to connect with our brand portfolio,” Dennis Bastas, Executive Chairman of Arrotex Pharmaceuticals said.
“The convenience of a whole of market approach through the PharmX EDI integration and the opportunity to present Brands, New Product Developments and promotions in a consistent way were also key factors.”
Corum Group Executive Chairman Nick England said: “The launch of PharmXchange delivers a key step in our strategy to enable trade between pharmacies and their suppliers through enhanced PharmX services.
“We are delighted that Arrotex along with other key pharmacy industry suppliers have recognised the opportunity that PharmXchange represents and have joined as commercial partners from the pilot launch.”
Pharmacies wishing to register for PharmXchange can do so by contacting: pharmacies@pharmxchange.com.au.
Suppliers wishing to learn more about PharmXchange can contact: suppliers@pharmxchange.com.au.
